Clinical Trial Update: Dose Effect Relationship of MTX and IBD

View source ↗

Summary

A completed clinical trial evaluating the dose–response relationship of methotrexate in inflammatory bowel disease and liver fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Liver Fibrosis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Inflammatory Bowel Diseases, Liver Fibroses | Status: COMPLETED